Growth Metrics

Bionano Genomics (BNGO) Share-based Compensation (2017 - 2025)

Bionano Genomics (BNGO) has disclosed Share-based Compensation for 9 consecutive years, with $926000.0 as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 52.17% to $926000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2025, down 53.43% year-over-year, with the annual reading at $4.5 million for FY2025, 53.43% down from the prior year.
  • Share-based Compensation hit $926000.0 in Q4 2025 for Bionano Genomics, down from $941000.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $6.1 million in Q3 2022 to a low of -$2.1 million in Q3 2021.
  • Historically, Share-based Compensation has averaged $2.7 million across 5 years, with a median of $2.6 million in 2024.
  • Biggest five-year swings in Share-based Compensation: tumbled 572.93% in 2021 and later skyrocketed 1275.2% in 2022.
  • Year by year, Share-based Compensation stood at -$2.1 million in 2021, then surged by 359.18% to $5.5 million in 2022, then crashed by 38.46% to $3.4 million in 2023, then tumbled by 42.59% to $1.9 million in 2024, then plummeted by 52.17% to $926000.0 in 2025.
  • Business Quant data shows Share-based Compensation for BNGO at $926000.0 in Q4 2025, $941000.0 in Q3 2025, and $1.1 million in Q2 2025.